Intravascular imaging during PCI: Should cardiologists choose IVUS or OCT?

The ACC released a new guideline asking interventional cardiologists to use intravascular imaging to improve outcomes in percutaneous coronary intervention (PCI). Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out. Image courtesy of Philips. 

Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out. Image courtesy of Philips. 

Which modality should care teams choose for PCI guidance? While there's an argument to be made for choosing IVUS over OCT, some specialists think the two treatment options are close to equal in terms of patient outcomes. 

SpectraWAVE raises $50M for FDA-cleared intravascular imaging technology

SpectraWAVE, a Massachusetts-based imaging company focused on treatments for patients with coronary artery disease (CAD), has closed a $50 million funding round. Johnson & Johnson Innovation led the round, and other participants included S3 Ventures, Lumira Ventures, SV Health Investors, Deerfield Management, NovaVenture and Heartwork Capital.

The HyperVue system uses both DeepOCT and near infrared spectroscopy (NIRS) imaging to help guide stent placement during interventional cardiology procedures.

The funds, including a significant investment from Johnson & Johnson, are expected to go toward expanding access to the company's HyperVue Imaging System and exploring new features.